Vasculitis is a rare but serious condition that involves inflammation of the blood vessels. This inflammation can affect ...

MANCHESTER, England — A soon-to-be-released guidance from the British Society for Rheumatology on the management of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) emphasizes ...

Patients with vs without ANCA-associated vasculitis are significantly more likely to die after kidney transplantation and to experience postoperative infection. Patients with ANCA-associated ...

The risk for major adverse cardiovascular events is a recognized, important complication reported among patients with ANCA-associated vasculitis. In patients with antineutrophil cytoplasmic antibody ...

Objective Postmarketing safety data of avacopan, the first Food and Drug Administration (FDA) approved drug in a decade for ...

There are two main goals of antineutrophil cytoplasmic antibodies (ANCA)associated vasculitis (AAV) treatment. The first goal is to bring the condition into remission by controlling active ...

While a diagnosis of antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, may seem daunting, it’s important to know that this chronic autoimmune disorder is no longer the ...

AAV is diagnosed based on symptoms listed above and the following laboratory tests. Based on which organs that may not be functioning well, imaging or biopsy may be performed. ANCA test, which is a ...

The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment of severe, active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, drugmaker ...

DelveInsight's“ ANCA Vasculitis Pipeline Insight 2025” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the ANCA Vasculitis pipeline landscape. It covers the ANCA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. IgG4-related disease (IgG4-RD) and antineutrophil ...